AstraZeneca buys drugmaker Caelum in deal worth up to $500 million - NewsBreak
#astrazeneca
#caelum
3 years ago By Sain — (Reuters) - AstraZeneca said on Wednesday its newly acquired Alexion division will purchase the remaining equity in drugmaker Caelum Biosciences in a deal